Published in J Aerosol Med on January 01, 2000
Ultrasonic drug delivery--a general review. Expert Opin Drug Deliv (2004) 1.94
Feasibility of tissue plasminogen activator formulated for pulmonary delivery. Pharm Res (2005) 0.90
Effect of formulation on the stability and aerosol performance of a nebulized antibody. MAbs (2014) 0.80
Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites. J Biol Chem (2015) 0.79
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet (2001) 2.15
Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br J Nutr (2001) 1.84
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. J Am Coll Cardiol (1991) 1.39
Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) (2004) 1.30
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. Am J Hum Genet (1997) 1.11
Protein C activation during the initial phase of experimental acute pancreatitis in the rabbit. Dig Surg (1999) 1.06
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas (2000) 1.00
Very small, very short-latency changes in human breathing induced by step changes of alveolar gas composition. J Physiol (1977) 0.97
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res (1996) 0.96
Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost (2000) 0.94
The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol (2000) 0.92
Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost (1999) 0.91
Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res (2000) 0.91
Neural ventilatory drive during arm and leg exercise. Scand J Clin Lab Invest (1972) 0.90
Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women. Maturitas (2001) 0.90
Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3. Am J Hum Genet (2001) 0.89
Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis. Br J Urol (1997) 0.88
Switching from DXA pencil-beam to fan-beam. I: Studies in vitro at four centers. Bone (1995) 0.87
Autosomal dominant osteopetrosis: bone mineral measurements of the entire skeleton of adults in two different subtypes. Bone (1995) 0.87
Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease. Lung (1999) 0.86
Premenopausal smoking and bone density in 2015 perimenopausal women. J Bone Miner Res (2000) 0.86
Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone (1998) 0.85
Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers. Am J Respir Crit Care Med (1999) 0.85
Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol (2000) 0.85
Biological variation of serum and urinary magnesium in apparently healthy males. Scand J Clin Lab Invest (1995) 0.84
Effect of inhaled heparin on lung function and coagulation in healthy volunteers. Eur Respir J (2002) 0.84
Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE). Osteoporos Int (2014) 0.83
Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone (1995) 0.83
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet (1995) 0.83
Ventilatory response to work initiated at various times during the respiratory cycle. J Appl Physiol (1972) 0.83
Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest (2007) 0.81
Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol (1997) 0.81
The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition. Thromb Res (1986) 0.81
Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study. Osteoporos Int (2010) 0.81
[The effect of liver cirrhosis on activation of the coagulation and fibrinolysis system and on coagulation inhibitors]. Med Klin (Munich) (1989) 0.81
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit? Thromb Haemost (1999) 0.80
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium. J Intern Med (1990) 0.80
The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum. Scand J Clin Lab Invest (1995) 0.80
Ventilation in man at onset of work employing different standardized starting orders. Respir Physiol (1971) 0.80
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction. Acta Med Scand (1987) 0.80
Serum levels of fetal antigen 2 in hyperthyroidism and primary hyperparathyroidism. APMIS (1992) 0.80
High bone mineral apparent density in children with X-linked hypophosphatemia. Osteoporos Int (2013) 0.79
Down-regulation of monocyte functions by treatment of healthy adults with 1 alpha,25 dihydroxyvitamin D3. Int J Immunopharmacol (1991) 0.79
Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study. Clin Endocrinol (Oxf) (1994) 0.79
Venous thrombosis after abdominal surgery. A comparison between subcutaneous heparin and antithrombotic stockings, or both. J Med (1988) 0.79
The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging. Thyroid (1996) 0.79
Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study. Calcif Tissue Int (2004) 0.79
Inhaled heparin is effective in exacerbations of asthma. Respir Med (2000) 0.78
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis (1997) 0.78
Effect of a short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodeling in adult male volunteers. Bone (1991) 0.78
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women. J Thromb Haemost (2003) 0.78
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics. Coron Artery Dis (1994) 0.78
Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled study. Scand J Clin Lab Invest (1991) 0.78
Influence of plasma platelets on activated protein C resistance assay. Thromb Haemost (1995) 0.78
Effects of inhaled plasminogen activator on the balance between coagulation and fibrinolysis in traumatized pigs. Blood Coagul Fibrinolysis (2002) 0.78
Depressed plasma fibrinolytic activity in a group of patients with connective tissue diseases. Scand J Rheumatol (1989) 0.78
Effects of hormone replacement therapy on hemostatic cardiovascular risk factors. Am J Obstet Gynecol (1999) 0.78
The relationship between maximal ventilation, breathing pattern and mechanical limitation of ventilation. J Physiol (1980) 0.77
Risk factors for osteoporosis and factors related to the use of DXA in Norway. Arch Osteoporos (2015) 0.77
Bronchodilator and corticosteroid reversibility in ambulatory patients with airways obstruction. Dan Med Bull (1991) 0.77
Evidence for a role of factor XII-dependent fibrinolysis in cardiovascular diseases. Ann N Y Acad Sci (1992) 0.77
Effects of methylamine and heparin on a rapid chromogenic assay of C1-esterase inhibitor in plasma. Clin Chem (1990) 0.77
Procoagulant activity and intimal dysfunction in IDDM. Diabetologia (1995) 0.77
Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes. Diabetes Obes Metab (2012) 0.77
Splanchnic extraction and clearance of tissue plasminogen activator (t-PA) after injection of recombinant t-PA (Actilyse) in resting healthy subjects is proportional to the arterial concentration. Blood Coagul Fibrinolysis (2002) 0.77
Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy: a randomized, placebo-controlled study. Lymphokine Cytokine Res (1991) 0.77
The short-latency respiratory response to sudden withdrawal of hypercapnia and hypoxia in man. Q J Exp Physiol (1981) 0.77
Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy. Scand J Clin Lab Invest (2001) 0.77
World distribution of factor V Leiden mutation. Lancet (1996) 0.77
Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1). Thromb Haemost (1993) 0.76
A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heart J (1990) 0.76
Heparin-free hypothermal hemodialysis at 20 degrees C improves biocompatibility. Blood Purif (1997) 0.76
Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarction. Eur Heart J (1993) 0.76
The possible role of oral epithelial cells in tissue-type plasminogen activator-related fibrinolysis in human saliva. J Dent Res (1990) 0.76
Relationship of glucose concentrations with PAI-1 and t-PA in subjects with normal glucose tolerance. Diabet Med (2006) 0.76
A sequential study of plasma histidine-rich glycoprotein and plasminogen in patients with acute myocardial infarction and deep vein thrombosis. Thromb Haemost (1984) 0.76
A selective depression of tissue plasminogen activator (t-PA) activity in euglobulins characterises a risk group among survivors of acute myocardial infarction. Thromb Haemost (1987) 0.76
Characterization of heparin aerosols generated in jet and ultrasonic nebulizers. J Aerosol Med (1999) 0.76
Proceedings: The use of transients in the study of the interactions of chemical drives to breathing. J Physiol (1976) 0.76
Improving compliance with hormonal replacement therapy in primary osteoporosis prevention. Maturitas (1997) 0.76
Plasma histidine-rich glycoprotein and plasminogen in patients with liver disease. Thromb Res (1985) 0.75
Patient's opinions about the routine use of tape recorders in rational behavior psychotherapy. J Natl Med Assoc (1972) 0.75
Cholesterol-lowering, simvastatin, and coronary heart disease. Lancet (1995) 0.75
Acquired activated protein-C resistance. Lancet (1999) 0.75
Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease. Heart (1997) 0.75
[Radiology on the Internet]. Ugeskr Laeger (1998) 0.75
The assay of factor Xa on a centrifugal analyzer. Thromb Res (1984) 0.75
Short-latency ventilatory responses to sudden withdrawal of hypoxia at normal and raised body temperature in man. Acta Physiol Scand (1978) 0.75
[Deep venous thrombosis in patients with acute myocardial infarction diagnosed by the 99mTc-plasmin test]. Ugeskr Laeger (1983) 0.75
[Lung mechanical parameters measured on flow-volume curves from 952 volunteers. Normal values in children and adults]. Ugeskr Laeger (1980) 0.75
[Lung mechanics evaluated by an Airflometer]. Ugeskr Laeger (1979) 0.75
On the diagnosis of deep venous thrombosis in patients at risk. Dan Med Bull (1984) 0.75
[Topical treatment of herpes zoster]. Ugeskr Laeger (1973) 0.75
Lung abscess with squamous epithelial lining. Respir Med (1998) 0.75
An unusual presentation of sarcoidosis with tetraplegia and severe osteolytic bone lesions. Eur Respir J (2011) 0.75
[Distribution of Br-82 between serum and cerebrospinal fluid in patients with meningitis]. Ugeskr Laeger (1977) 0.75
Modification of the immediate plasmin inhibition assay to secure linearity of the reference curve with the chromogenic substrate S-2251. Thromb Haemost (1984) 0.75